KDM5B and breast carcinoma: In breast cancer it has been reported that the depletion of Jarid1b led to inhibition of breast cancer cell proliferation and to reduce tumor growth in xenografts15 or syngeneic mouse mammary tumor model.16 Similar results were obtained in lung cancer, bladder cancer and colorectal tumors.